Literature DB >> 18528804

Serious postpartum infection due to MRSA in an asymptomatic carrier: case report and review.

Paul G Stumpf1, Marisol Flores, Jeremias Murillo.   

Abstract

Infection with methicillin-resistant Staphylococcus aureus (MRSA) has become a worldwide problem and is no longer acquired only in a hospital setting. Community-associated MRSA is an emerging pathogen of increasing interest to both obstetricians and neonatologists, reported in all three trimesters of pregnancy and postpartum, and in neonatal intensive care units, leading to severe outcomes, including neonatal death. This case report describes a serious and potentially life-threatening infection (including wound abscess, septicemia, septic thrombophlebitis, and septic pulmonary emboli) that developed in an otherwise healthy postpartum woman who had screened positive for MRSA in nares, vagina, and rectum at the time of her prior admission in labor as part of a research study. We conclude that asymptomatic nasal, vaginal, and rectal colonization with MRSA occurs in pregnancy and may be a risk factor for serious systemic infection after delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528804     DOI: 10.1055/s-2008-1075032

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  3 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 2.  The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.

Authors:  Linda P Arendsen; Ranee Thakar; Abdul H Sultan
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

3.  Transplacental transfer of vancomycin and telavancin.

Authors:  Tatiana Nanovskaya; Svetlana Patrikeeva; Ying Zhan; Valentina Fokina; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Am J Obstet Gynecol       Date:  2012-08-04       Impact factor: 8.661

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.